In one such trial it was reported that in 97% of opiate-dependent and 87% of alcohol-dependent patients the symptoms were alleviated by DSIP administration.
In 97% of opiate-dependent and 87% of alcohol-dependent patients, symptom relief was observed after DSIP administration.